Cohance Lifesciences Limited
924words
0turns
0analyst exchanges
0executives
Key numbers — 29 extracted
2.71%
es in Rs. Crore 5 Financial Snapshot Q1FY22 Growth in Revenue Growth in EBITDA Growth in PAT 2.71% 24.13% 26.36% 6 Key Ratios Q1FY22 EBIT to Income EBITDA to Income PAT to Income 41.33%
24.13%
s. Crore 5 Financial Snapshot Q1FY22 Growth in Revenue Growth in EBITDA Growth in PAT 2.71% 24.13% 26.36% 6 Key Ratios Q1FY22 EBIT to Income EBITDA to Income PAT to Income 41.33% 44.66%
26.36%
5 Financial Snapshot Q1FY22 Growth in Revenue Growth in EBITDA Growth in PAT 2.71% 24.13% 26.36% 6 Key Ratios Q1FY22 EBIT to Income EBITDA to Income PAT to Income 41.33% 44.66% 30.21%
41.33%
T 2.71% 24.13% 26.36% 6 Key Ratios Q1FY22 EBIT to Income EBITDA to Income PAT to Income 41.33% 44.66% 30.21% 7 Financials Q1FY22 Revenue EBIDTA PAT EPS 2,625 2,696 2,440 1,174 1,204
44.66%
24.13% 26.36% 6 Key Ratios Q1FY22 EBIT to Income EBITDA to Income PAT to Income 41.33% 44.66% 30.21% 7 Financials Q1FY22 Revenue EBIDTA PAT EPS 2,625 2,696 2,440 1,174 1,204 970 8
30.21%
26.36% 6 Key Ratios Q1FY22 EBIT to Income EBITDA to Income PAT to Income 41.33% 44.66% 30.21% 7 Financials Q1FY22 Revenue EBIDTA PAT EPS 2,625 2,696 2,440 1,174 1,204 970 812 814
38%
Y21 Q1FY22 Q1FY21 Q4FY21 Q1FY22 8 Financials Q1FY22 EBITDA Margin (%) PAT Margin (%) 38% 37% 45% 33% 25% 30% Q1FY21 Q4FY21 Q1FY22 Q1FY21 Q4FY21 Q1FY22 9 Financial Table – Q1 F
37%
1FY22 Q1FY21 Q4FY21 Q1FY22 8 Financials Q1FY22 EBITDA Margin (%) PAT Margin (%) 38% 37% 45% 33% 25% 30% Q1FY21 Q4FY21 Q1FY22 Q1FY21 Q4FY21 Q1FY22 9 Financial Table – Q1 FY22
45%
Q1FY21 Q4FY21 Q1FY22 8 Financials Q1FY22 EBITDA Margin (%) PAT Margin (%) 38% 37% 45% 33% 25% 30% Q1FY21 Q4FY21 Q1FY22 Q1FY21 Q4FY21 Q1FY22 9 Financial Table – Q1 FY22 Reve
33%
Y21 Q4FY21 Q1FY22 8 Financials Q1FY22 EBITDA Margin (%) PAT Margin (%) 38% 37% 45% 33% 25% 30% Q1FY21 Q4FY21 Q1FY22 Q1FY21 Q4FY21 Q1FY22 9 Financial Table – Q1 FY22 Revenue E
25%
4FY21 Q1FY22 8 Financials Q1FY22 EBITDA Margin (%) PAT Margin (%) 38% 37% 45% 33% 25% 30% Q1FY21 Q4FY21 Q1FY22 Q1FY21 Q4FY21 Q1FY22 9 Financial Table – Q1 FY22 Revenue EBITDA
30%
Q1FY22 8 Financials Q1FY22 EBITDA Margin (%) PAT Margin (%) 38% 37% 45% 33% 25% 30% Q1FY21 Q4FY21 Q1FY22 Q1FY21 Q4FY21 Q1FY22 9 Financial Table – Q1 FY22 Revenue EBITDA EBIT
Advertisement